Literature DB >> 22943200

Phagocytosis of apoptotic cells by macrophages in anti-neutrophil cytoplasmic antibody-associated systemic vasculitis.

S M Ohlsson1, Å Pettersson, S Ohlsson, D Selga, A A Bengtsson, M Segelmark, T Hellmark.   

Abstract

Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) is a group of autoimmune diseases, including granulomatosis with polyangiitis (GPA) and microscopic polyangiitis (MPA). It is not known why ANCA develop, but it has been shown that they participate in pathogenesis by activating polymorphonuclear neutrophils (PMNs). In this study we hypothesize that dysregulation of phagocytosis in AAV leads to the accumulation of apoptotic neutrophils seen in association with blood vessels in AAV. These cells progress into secondary necrosis, contributing to tissue damage and autoantibody formation. Peripheral blood cells were counted, and phagocytosis was investigated using monocyte-derived macrophages (MØ) and PMNs from healthy blood donors (HBD), AAV patients and systemic lupus erythematosus (SLE) patients. Furthermore, the effect of serum was assessed. Phagocytosis was measured using flow cytometry. The results showed no deviation in monocyte subpopulations for AAV patients compared to HBDs, although there was a decrease in lymphocyte and pDC (plasmacytoid dendritic cell) populations (4·2 × 10(6) cells/l versus 10·4 × 10(6) cells/l, P < 0·001). The number of neutrophils was increased (6·0 × 10(9) cells/l versus 3·8 × 10(9) cells/l, P < 0·001). There were no differences found in the ability of MØs to engulf apoptotic cells, nor when comparing apoptotic PMNs to become engulfed. However, serum from AAV donors tended to decrease the phagocytosis ability of MØs (36%) compared to serum from HBDs (43%). In conclusion, there is no intrinsic dysfunction in the MØs or in the PMNs that have an effect on phagocytic activity, but ANCA may play a role by decreasing phagocytic ability.
© 2012 The Authors. Clinical and Experimental Immunology © 2012 British Society for Immunology.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22943200      PMCID: PMC3444716          DOI: 10.1111/j.1365-2249.2012.04633.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  43 in total

1.  Interaction of human peripheral blood monocytes with apoptotic polymorphonuclear cells.

Authors:  Tomasz P Mikołajczyk; Joanna E Skrzeczyńska-Moncznik; Mirosław A Zarebski; Ewa A Marewicz; Anna M Wiśniewska; Magdalena Dzieba; Jerzy W Dobrucki; Juliusz R Pryjma
Journal:  Immunology       Date:  2009-09       Impact factor: 7.397

2.  Granulomatosis with polyangiitis (Wegener's): an alternative name for Wegener's granulomatosis.

Authors:  Ronald J Falk; Wolfgang L Gross; Loïc Guillevin; Gary Hoffman; David R W Jayne; J Charles Jennette; Cees G M Kallenberg; Raashid Luqmani; Alfred D Mahr; Eric L Matteson; Peter A Merkel; Ulrich Specks; Richard Watts
Journal:  Ann Rheum Dis       Date:  2011-04       Impact factor: 19.103

Review 3.  The innate immune system and the clearance of apoptotic cells.

Authors:  Andrew Devitt; Lindsay J Marshall
Journal:  J Leukoc Biol       Date:  2011-05-11       Impact factor: 4.962

4.  Anti-LAMP-2 antibodies are not prevalent in patients with antineutrophil cytoplasmic autoantibody glomerulonephritis.

Authors:  Aleeza J Roth; Michael C Brown; Rex Neal Smith; Anshul K Badhwar; Oscar Parente; Hyun chul Chung; Donna O'Dell Bunch; JulieAnne G McGregor; Susan L Hogan; Yichun Hu; Jia-Jin Yang; Elisabeth A Berg; John Niles; J Charles Jennette; Gloria A Preston; Ronald J Falk
Journal:  J Am Soc Nephrol       Date:  2011-10-21       Impact factor: 10.121

Review 5.  The pathophysiologic role of monocytes and macrophages in systemic lupus erythematosus: a reappraisal.

Authors:  Christina G Katsiari; Stamatis-Nick C Liossis; Petros P Sfikakis
Journal:  Semin Arthritis Rheum       Date:  2009-01-15       Impact factor: 5.532

Review 6.  Interaction of proteinase 3 with its associated partners: implications in the pathogenesis of Wegener's granulomatosis.

Authors:  Véronique Witko-Sarsat; Nathalie Reuter; Luc Mouthon
Journal:  Curr Opin Rheumatol       Date:  2010-01       Impact factor: 5.006

7.  High prevalence of autoantibodies to hLAMP-2 in anti-neutrophil cytoplasmic antibody-associated vasculitis.

Authors:  Renate Kain; Henko Tadema; Eoin F McKinney; Alexandra Benharkou; Ricarda Brandes; Andrea Peschel; Virginie Hubert; Tjerk Feenstra; Gürkan Sengölge; Coen Stegeman; Peter Heeringa; Paul A Lyons; Kenneth G C Smith; Cees Kallenberg; Andrew J Rees
Journal:  J Am Soc Nephrol       Date:  2012-02-09       Impact factor: 14.978

8.  Decreased numbers of blood dendritic cells and defective function of regulatory T cells in antineutrophil cytoplasmic antibody-associated vasculitis.

Authors:  Marie Rimbert; Mohamed Hamidou; Cécile Braudeau; Xavier Puéchal; Luis Teixeira; Hélène Caillon; Antoine Néel; Marie Audrain; Loic Guillevin; Régis Josien
Journal:  PLoS One       Date:  2011-04-08       Impact factor: 3.240

9.  Differentiation and glucocorticoid regulated apopto-phagocytic gene expression patterns in human macrophages. Role of Mertk in enhanced phagocytosis.

Authors:  Gábor Zahuczky; Endre Kristóf; Gyöngyike Majai; László Fésüs
Journal:  PLoS One       Date:  2011-06-24       Impact factor: 3.240

10.  Anti-proteinase 3 anti-neutrophil cytoplasm autoantibodies recapitulate systemic vasculitis in mice with a humanized immune system.

Authors:  Mark A Little; Bahjat Al-Ani; Shuyu Ren; Hamad Al-Nuaimi; Maurilo Leite; Charles E Alpers; Caroline O Savage; Jeremy S Duffield
Journal:  PLoS One       Date:  2012-01-11       Impact factor: 3.240

View more
  7 in total

Review 1.  Intravascular immunity as a key to systemic vasculitis: a work in progress, gaining momentum.

Authors:  G A Ramirez; N Maugeri; M G Sabbadini; P Rovere-Querini; A A Manfredi
Journal:  Clin Exp Immunol       Date:  2014-02       Impact factor: 4.330

Review 2.  Trial watch: Immunogenic cell death induction by anticancer chemotherapeutics.

Authors:  Abhishek D Garg; Sanket More; Nicole Rufo; Odeta Mece; Maria Livia Sassano; Patrizia Agostinis; Laurence Zitvogel; Guido Kroemer; Lorenzo Galluzzi
Journal:  Oncoimmunology       Date:  2017-10-04       Impact factor: 8.110

Review 3.  Tuberculosis and Autoimmunity.

Authors:  Irina V Belyaeva; Anna N Kosova; Andrei G Vasiliev
Journal:  Pathophysiology       Date:  2022-06-13

4.  A myelopoiesis gene signature during remission in anti-neutrophil cytoplasm antibody-associated vasculitis does not predict relapses but seems to reflect ongoing prednisolone therapy.

Authors:  T Kurz; M Weiner; C Skoglund; S Basnet; P Eriksson; M Segelmark
Journal:  Clin Exp Immunol       Date:  2014-02       Impact factor: 4.330

5.  CD14 expression is increased on monocytes in patients with anti-neutrophil cytoplasm antibody (ANCA)-associated vasculitis and correlates with the expression of ANCA autoantigens.

Authors:  R M Tarzi; J Liu; S Schneiter; N R Hill; T H Page; H T Cook; C D Pusey; K J Woollard
Journal:  Clin Exp Immunol       Date:  2015-07       Impact factor: 4.330

6.  High-Dimensional Profiling Reveals Heterogeneity of the Th17 Subset and Its Association With Systemic Immunomodulatory Treatment in Non-infectious Uveitis.

Authors:  Fleurieke H Verhagen; Sanne Hiddingh; Rianne Rijken; Aridaman Pandit; Emmerik Leijten; Michel Olde Nordkamp; Ninette H Ten Dam-van Loon; Stefan Nierkens; Saskia M Imhof; Joke H de Boer; Timothy R D J Radstake; Jonas J W Kuiper
Journal:  Front Immunol       Date:  2018-10-31       Impact factor: 7.561

Review 7.  Trial watch: chemotherapy-induced immunogenic cell death in immuno-oncology.

Authors:  Isaure Vanmeerbeek; Jenny Sprooten; Dirk De Ruysscher; Sabine Tejpar; Peter Vandenberghe; Jitka Fucikova; Radek Spisek; Laurence Zitvogel; Guido Kroemer; Lorenzo Galluzzi; Abhishek D Garg
Journal:  Oncoimmunology       Date:  2020-01-09       Impact factor: 8.110

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.